Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

iRhythm Technologies, Inc. - Common Stock (NQ:IRTC)

100.34 -5.58 (-5.27%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 405,548
Open 101.65
Bid (Size) 91.01 (32)
Ask (Size) 128.40 (14)
Prev. Close 105.92
Today's Range 96.66 - 102.94
52wk Range 55.92 - 128.52
Shares Outstanding 29,403,360
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks
Looking back on patient monitoring stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection
Two large studies of over one million patients reveal that short-term Holter-duration monitoring frequently misses actionable arrhythmias and that patient-reported symptoms are an unreliable predictor... 
From iRhythm
Via GlobeNewswire

Performance

YTD
+12.2%
+12.2%
1 Month
-6.8%
-6.8%
3 Month
+10.5%
+10.5%
6 Month
+60.0%
+60.0%
1 Year
-6.5%
-6.5%

More News

Read More
Breaking Down iRhythm Technologies: 6 Analysts Share Their Views
Via Benzinga
Earnings Scheduled For February 20, 2025
Via Benzinga
Critical Insights From iRhythm Technologies Analyst Ratings: What You Need To Know
Via Benzinga
Forecasting The Future: 6 Analyst Projections For iRhythm Technologies
Via Benzinga
3 Healthcare Stocks in the Doghouse
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried
Via Investor's Business Daily
1 Growth Stock to Target This Week and 2 to Ignore
Via StockStory
Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
iRhythm (NASDAQ:IRTC) Reports Strong Q4, Stock Soars
Via StockStory
iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results
From iRhythm
Via GlobeNewswire
iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
From iRhythm
Via GlobeNewswire
iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference
From iRhythm
Via GlobeNewswire
iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From iRhythm
Via GlobeNewswire
Top 3 Robotics and Automation Stocks for the Next AI Boom
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Via Benzinga
iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference
From iRhythm
Via GlobeNewswire
iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring
From iRhythm
Via GlobeNewswire
iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference
From iRhythm
Via GlobeNewswire
IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device
From iRhythm
Via GlobeNewswire

Frequently Asked Questions

Is iRhythm Technologies, Inc. - Common Stock publicly traded?
Yes, iRhythm Technologies, Inc. - Common Stock is publicly traded.
What exchange does iRhythm Technologies, Inc. - Common Stock trade on?
iRhythm Technologies, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for iRhythm Technologies, Inc. - Common Stock?
The ticker symbol for iRhythm Technologies, Inc. - Common Stock is IRTC on the Nasdaq Stock Market
What is the current price of iRhythm Technologies, Inc. - Common Stock?
The current price of iRhythm Technologies, Inc. - Common Stock is 100.34
When was iRhythm Technologies, Inc. - Common Stock last traded?
The last trade of iRhythm Technologies, Inc. - Common Stock was at 04/04/25 04:00 PM ET
What is the market capitalization of iRhythm Technologies, Inc. - Common Stock?
The market capitalization of iRhythm Technologies, Inc. - Common Stock is 2.95B
How many shares of iRhythm Technologies, Inc. - Common Stock are outstanding?
iRhythm Technologies, Inc. - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.